DRDamiana D. Rosa

Damiana D. Rosa

*This is an algorithmically generated author record based on publicly available information.

Damiana D. Rosa has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Lisiane Lopes da Conceição

    Department of Nutrition and Health, Universidade Federal de Viçosa, Viçosa, Minas Gerais, 36570-900, Brazil

    2 shared publications
  • Maria Do Carmo G. Peluzio

    Department of Nutrition and Health,Universidade Federal de Viçosa,Minas Gerais,36571-900,Brazil

    2 shared publications
  • Sandra A. Reis

    Department of Nutrition and Health,Universidade Federal de Viçosa,Minas Gerais,36571-900,Brazil

    2 shared publications
  • Łukasz Grześkowiak

    Institute of Animal Nutrition, Department of Veterinary Medicine, Freie Universität Berlin, 14195 Berlin, Germany

    2 shared publications
  • Alessandra B. F. Machado

    Department of Microbiology, Immunology and Parasitology, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil

    1 shared publication
  • Ana Carolina M. Fonseca

    Department of Nutrition and Health, Universidade Federal de Vicosa, Vicosa, Brazil

    1 shared publication

Latest Publications

  • Top Cited Papers

    Milk kefir: nutritional, microbiological and health benefits

    by Damiana D. Rosa, Manoela M. S. Dias, Łukasz M. Grześkowiak, Sandra A. Reis, Lisiane L. Conceição, Maria Do Carmo G. Peluzio

    Kefir is fermented milk produced from grains that comprise a specific and complex mixture of bacteria and yeasts that live in a symbiotic association. The nutritional composition of kefir varies according to the milk composition, the microbiological composition of the grains used, the time/temperature of fermentation and storage conditions. Kefir originates from the Caucasus and Tibet. Recently, kefir has raised interest in the scientific community due to its numerous beneficial effects on health. Currently, several scientific studies have supported the health benefits of kefir, as reported historically as a probiotic drink with great potential in health promotion, as well as being a safe and inexpensive food, easily produced at home. Regular consumption of kefir has been associated with improved digestion and tolerance to lactose, antibacterial effect, hypocholesterolaemic effect, control of plasma glucose, anti-hypertensive effect, anti-inflammatory effect, antioxidant activity, anti-carcinogenic activity, anti-allergenic activity and healing effects. A large proportion of the studies that support these findings were conducted in vitro or in animal models. However, there is a need for systematic clinical trials to better understand the effects of regular use of kefir as part of a diet, and for their effect on preventing diseases. Thus, the present review focuses on the nutritional and microbiological composition of kefir and presents relevant findings associated with the beneficial effects of kefir on human and animal health.


  • Review of the mechanisms of probiotic actions in the prevention of colorectal cancer

    by Sandra A. dos Reis, Lisiane L. da Conceição, Nathane P. Siqueira, Damiana D. Rosa, Letícia L. da Silva, Maria Do Carmo G. Peluzio


  • Kefir reduces insulin resistance and inflammatory cytokine expression in an animal model of metabolic syndrome

    by Damiana D. Rosa, Łukasz M. Grześkowiak, Célia L. L. F. Ferreira, Ana Carolina M. Fonseca, Sandra A. Reis, Mariana M. Dias, Nathane P. Siqueira, Leticia L. Silva, Clóvis A. Neves, Leandro L. Oliveira, et al.

    There is growing evidence that kefir can be a promising tool in decreasing the risk of many diseases, including metabolic syndrome (MetS). The aim of the present study was to evaluate the effect of kefir supplementation in the diet of Spontaneously Hypertensive Rats (SHR) in which MetS was induced with monosodium glutamate (MSG), and to determine its effect on metabolic parameters, inflammatory and oxidation marker expression and glycemic index control. Thirty animals were used in this experiment. For the induction of MetS, twenty two-day-old male SHR received five consecutive intradermal injections of MSG. For the Negative Control, ten newborn male SHR received intradermal injections of saline solution (0.9% saline solution). After weaning, animals received standard diet and water ad libitum until reaching 3 months old, for the development of MetS. They were then divided into three groups (n = 10): negative control (NC, 1 mL saline solution per day), positive control (PC, 1 mL saline solution per day) and the Kefir group (1 mL kefir per day). Feeding was carried out by gavage for 10 weeks and the animals received standard food and water ad libitum. Obesity, insulin resistance, pro- and anti-inflammatory markers, and the histology of pancreatic and adipose tissues were among the main variables evaluated. Compared to the PC group, kefir supplementation reduced plasma triglycerides, liver lipids, liver triglycerides, insulin resistance, fasting glucose, fasting insulin, thoracic circumference, abdominal circumference, products of lipid oxidation, pro-inflammatory cytokine expression (IL-1β) and increased anti-inflammatory cytokine expression (IL-10). The present findings indicate that kefir has the potential to benefit the management of MetS.